Rachel Shireen Golpanian, MD, Department of Dermatology and Cutaneous Surgery and Itch Center. University of Miami Miller School of Medicine, Miami, FL.
Juan M. Gonzalez, DNP, University of Miami School of Nursing & Health Studies, Coral Gables, FL.
Gil Yosipovitch, MD, Department of Dermatology and Cutaneous Surgery and Itch Center, University of Miami Miller School of Medicine, Miami, FL.
Dr. Yosipovitch is a scientific board member of Menlo, Trevi, Sanofi Regeneron, Galderma, Pfizer, Novartis, Kiniksa, Eli Lilly, Leo, and Bellus. Research support was given by Pfizer, Sun Pharma, Leo, Novartis, and Kiniksa. The other authors declare no conflict of interest.
Correspondence concerning this article should be addressed to Gil Yosipovitch, MD, Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery and Miami Itch Center, University of Miami Miller School of Medicine, 1600 NW 10th Avenue, RMSB 7097, Miami, FL 33136. E-mail: [email protected]
